PMCB
PharmaCyte Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.45
+5.02%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-54.9%
Return on equity
-44.0%
Return on assets
-23.9%
Return on invested capital
0.00x
Asset turnover
-$3.9M
Cash from operations
$2.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026